This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Opexa Therapeutics Inc
OPXA : NASDAQ : Health Care
$1.08 -0.03 | -2.70%
Today's Range: 1.08 - 1.18
Avg. Daily Volume: 132,800
09/17/14 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
OPXA OPEXA THERAPEUTICS INC 1.27 35.25 n/m 1.36 138.13
LPDX LIPOSCIENCE INC 3.20 48.88 n/m 46.51 -13.95
OGEN ORAGENICS INC 1.31 47.39 n/m 1.21 16.07
NSPH NANOSPHERE INC 0.61 46.91 n/m 11.74 76.34
IBIO IBIO INC 0.62 40.70 n/m 0.66 -13.45
GNVC GENVEC INC 2.28 39.38 n/m 3.99 -28.86
RXII RXI PHARMACEUTICALS CORP 2.19 35.27 n/m 0.16 -56.80
CBLI CLEVELAND BIOLABS INC 0.44 25.13 n/m 7.40 38.10
XTLB XTL BIOPHARMACEUTICALS 2.01 23.84 n/m 2.15 1.31
DARA DARA BIOSCIENCES INC 1.17 22.82 n/m 0.89 486.84
ICCC IMMUCELL CORP 4.45 13.47 n/m 6.42 12.32
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

OPXA Ind Avg S&P 500
n/m 81.35 19.67

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs